IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 214 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 0.89 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,382 | +11431.6% | 455 | -77.4% | 0.00% | -100.0% |
| Q4 2022 | $38 | -99.9% | 2,013 | +0.4% | 0.00% | 0.0% |
| Q3 2022 | $38,000 | 0.0% | 2,005 | -1.0% | 0.00% | 0.0% |
| Q2 2022 | $38,000 | 0.0% | 2,026 | 0.0% | 0.00% | – |
| Q1 2022 | $38,000 | – | 2,026 | – | 0.00% | – |
| Q2 2021 | $0 | – | 0 | – | 0.00% | – |
| Q1 2021 | $0 | – | 0 | – | 0.00% | – |
| Q4 2020 | $0 | -100.0% | 0 | -100.0% | 0.00% | – |
| Q3 2020 | $1,000 | 0.0% | 140 | 0.0% | 0.00% | – |
| Q2 2020 | $1,000 | 0.0% | 140 | 0.0% | 0.00% | – |
| Q1 2020 | $1,000 | – | 140 | – | 0.00% | – |
| Q4 2019 | $0 | – | 0 | – | 0.00% | – |
| Q3 2019 | $0 | -100.0% | 0 | -100.0% | 0.00% | – |
| Q3 2018 | $1,000 | 0.0% | 49 | -19.7% | 0.00% | – |
| Q2 2018 | $1,000 | 0.0% | 61 | -7.6% | 0.00% | – |
| Q2 2017 | $1,000 | – | 66 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 16,390,000 | $172,422,800 | 22.05% |
| 13D Management LLC | 533,562 | $5,613,073 | 2.85% |
| Quantedge Capital Pte Ltd | 541,200 | $5,693,424 | 2.22% |
| Price Jennifer C. | 520,000 | $5,470,400 | 1.74% |
| Tamarack Advisers, LP | 210,000 | $2,209,200 | 0.81% |
| Intrinsic Value Partners, LLC | 51,605 | $542,885 | 0.73% |
| Brown Capital Management | 3,933,933 | $41,384,975 | 0.62% |
| Old West Investment Management, LLC | 75,219 | $791,303 | 0.43% |
| EMC Capital Management | 43,315 | $456 | 0.38% |
| Hillsdale Investment Management Inc. | 420,617 | $4,424,891 | 0.38% |